Target
D(3) dopamine receptor
Ligand
BDBM476886
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.080±n/a nM
Citation
 Tobinaga, HMasuda, KInagaki, MYonehara, MMasuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent  US10870660 Publication Date 12/22/2020 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM476886
Synonyms:
US10870660, Compound I-073 | US11345716, Compound I-073
Type:
Small organic molecule
Emp. Form.:
C29H35N5OS
Mol. Mass.:
501.686
SMILES:
O=C(N[C@H]1CC[C@H](CCN2CCc3sc(nc3C2)N2CC3CC3C2)CC1)c1cccc2ncccc12 |r,wU:6.6,wD:3.2,(7.14,-.77,;7.14,.77,;5.81,1.54,;4.47,.77,;3.14,1.54,;1.81,.77,;1.81,-.77,;.47,-1.54,;-.86,-.77,;-2.19,-1.54,;-2.19,-3.08,;-3.53,-3.85,;-4.86,-3.08,;-6.33,-3.56,;-7.23,-2.31,;-6.33,-1.06,;-4.86,-1.54,;-3.53,-.77,;-8.77,-2.31,;-9.68,-1.06,;-11.14,-1.54,;-12.48,-2.31,;-11.14,-3.08,;-9.68,-3.56,;3.14,-1.54,;4.47,-.77,;8.47,1.54,;8.47,3.08,;9.81,3.85,;11.14,3.08,;11.14,1.54,;12.48,.77,;12.48,-.77,;11.14,-1.54,;9.81,-.77,;9.81,.77,)|
Structure:
Search PDB for entries with ligand similarity: